Assignee
CELLPHIRE INC
US14 patents
Top patents by PatentIndex Score
US7811558B2Oct 12, 2010
Use of stabilized platelets as hemostatic agent
CELLPHIRE INC42 citations92
US11529587B2Dec 20, 2022
Materials and methods for producing blood products
CELLPHIRE INC15 citations91
US11767511B2Sep 26, 2023
Platelets as delivery agents
CELLPHIRE INC6 citations84
US11701388B2Jul 18, 2023
Thrombosomes as an antiplatelet agent reversal agent
CELLPHIRE INC10 citations83
US11813572B2Nov 14, 2023
Materials and methods for producing blood products
CELLPHIRE INC5 citations82
US11752468B2Sep 12, 2023
Materials and methods for producing blood products
CELLPHIRE INC7 citations82
US12208122B2Jan 28, 2025
Methods of treating bleeding in a subject treated with an antiplatelet agent
CELLPHIRE INC2 citations72
US12378523B2Aug 5, 2025
Platelets as delivery agents
CELLPHIRE INC0 citations61
US12419914B2Sep 23, 2025
Thrombosomes as an antiplatelet agent reversal agent
CELLPHIRE INC0 citations60
US12370219B2Jul 29, 2025
Platelet derivative compositions, and pluralities of containers containing same
CELLPHIRE INC0 citations59
US12295972B2May 13, 2025
Methods using freeze-dried platelet derivative compositions for restoring hemostasis in a subject
CELLPHIRE INC0 citations59
US12290532B2May 6, 2025
Treatment of von Willebrand disease
CELLPHIRE INC0 citations58
US11903971B2Feb 20, 2024
Treatment of von Willebrand disease
CELLPHIRE INC0 citations58
US11965178B2Apr 23, 2024
Platelets loaded with anti-cancer agents
CELLPHIRE INC0 citations43